Review our resources for client conversations.
Help clients understand how our distinct business model funds innovative medical research.
We're always looking for exceptional team members.
By Mike Liss - April 17, 2018
It’s been a rough period for value. With the value index underperforming the growth index in large cap stocks by 2,000 basis points over the past year, I would say this is likely the most we’ve been out of favor since I started in 1998.
But the value strategy is still where my passion lies, and I see plenty of opportunity on the horizon. Right now, my focus is on energy. Healthcare is also on my radar, and specifically pharmaceuticals and medical technology. In this quarter’s outlook, I focus on that and why bottom-up investors still pay attention to the top down.
A-shares are shares of mainland China-based companies that are traded the Shanghai Stock Exchange and the Shenzhen Stock Exchange in local currency. The addition of these shares to MSCI's widely followed indexes is expected to spur billions of dollars in foreign investment in the Chinese market.
June 07, 2018
Now more than ever, it is easy to get distracted by daily news flow. Between attention-grabbing headlines and the viral nature of social media, the news can be a lot to absorb. Our Premier Growth strategy team, however, remains focused on investing in competitively advantaged companies.
April 27, 2018
The recent negative equity market response—despite limited economic exposures—reflects how markets are trying to price in the risk of escalated US protectionism, rather than any specific tariff. We believe the steel and aluminum tariffs will have a limited impact on emerging markets.
March 09, 2018
While the end of 2018 may have been rocky for financial markets, our value team is excited about their prospects in 2019.
February 6, 2019
Tariffs. Rising rates. Geopolitical turmoil. None of this deters Sr. Portfolio Manager Mike Liss on his mission to turn high-quality companies underperforming into shareholder return. See which industries are on his radar this quarter.
April 17, 2018
Value equity Sr. PM Mike Liss sees good risk-reward opportunities in the energy and pharmaceutical sectors in 2018.
January 05, 2018
The opinions expressed are those of American Century Investments (or the portfolio manager) and are no guarantee of the future performance of any American Century Investments' portfolio. This material has been prepared for educational purposes only. It is not intended to provide, and should not be relied upon for, investment, accounting, legal or tax advice.